ELUT vs UTHR · rev $12.3M vs P/E 20, rev $1.56B
Elutia Inc. (ELUT) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Elutia Inc. (ELUT) is a medical devices company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ELUT revenue for 2025-12-31 was $12.3M. Net income was $53.4M. ELUT currently screens at market cap $101.1M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
ELUT currently screens at market cap $101.1M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the ELUT and UTHR stock pages for the full models.
Not investment advice.